Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer

BJU International

Volumn 109, Issue 1, 2012, Pages 70-76

  Boström, Peter J ^a,b   Alkhateeb, Sultan ^a   Trottier, Greg ^a   Athanasopoulos, Paul Z ^a   Mirtti, Tuomas ^a   Kortekangas, Hannes ^b   Laato, Matti ^b   Van Rhijn, Bas ^a   Van Der Kwast, Theo ^c   Fleshner, Neil E ^a   Jewett, Michael A ^a   Finelli, Antonio ^a   Zlotta, Alexandre R ^a,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

bladder cancer; radical cystectomy; smoking; survival; tobacco

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SURVIVAL RATE;

AGED; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; ONTARIO; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SMOKING; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 83555174868     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10371.x     Document Type: Article

References (22)

1. Burch J, Rohan T, Howe G, et al,. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer 1989; 44: 622-8 (Pubitemid 19258734)
2. Baris D, Karagas M, Verrill C, et al,. A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst 2009; 101: 1553-61
3. Zeegers M, Tan F, Dorant E, van Den Brandt P,. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000; 89: 630-9 (Pubitemid 30640110)
4. Van Hemelrijck M, Michaud D, Connolly G, Kabir Z,. Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses. Cancer Epidemiol Biomarkers Prev 2009; 18: 1312-20
5. Aveyard P, Adab P, Cheng K, Wallace D, Hey K, Murphy M,. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 2002; 90: 228-39 (Pubitemid 34989068)
6. Fleshner N, Garland J, Moadel A, et al,. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 1999; 86: 2337-45 (Pubitemid 30010376)
7. Sturgeon S, Hartge P, Silverman D, et al,. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994; 5: 218-25 (Pubitemid 24073396)
8. Hayes R, Friedell G, Zahm S, Cole P,. Are the known bladder cancer risk-factors associated with more advanced bladder cancer? Cancer Causes Control 1993; 4: 157-62 (Pubitemid 23077023)
9. van der Kwast T, Bapat B,. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling. Curr Opin Urol 2009; 19: 516-21
10. Wallerand H, Bakkar A, de Medina S, et al,. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens. Carcinogenesis 2005; 26: 177-84 (Pubitemid 40207713)
11. Stein J, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term Results in 1,054 patients. J Clin Oncol 2001; 19: 666-75 (Pubitemid 32120143)
12. Madersbacher S, Hochreiter W, Burkhard F, et al,. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 21: 690-6 (Pubitemid 46621904)
13. Shariat S, Karakiewicz P, Palapattu G, et al,. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414-22 (Pubitemid 44755069)
14. Thrasher J, Frazier H, Robertson J, Dodge R, Paulson D,. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1994; 73: 1708-15 (Pubitemid 24085274)
15. Mungan N, Kiemeney L, van Dijck J, van der Poel H, Witjes J,. Gender differences in stage distribution of bladder cancer. Urology 2000; 55: 368-71 (Pubitemid 30110586)
16. Madeb R, Messing E,. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004; 22: 86-92 (Pubitemid 38479800)
17. Kulkarni G, Urbach D, Austin P, Fleshner N, Laupacis A,. Longer wait times increase overall mortality in patients with bladder cancer. J Urol 2009; 182: 1318-24
18. Fradet Y, Aprikian A, Dranitsaris G, et al,. Does prolonging the time to bladder cancer surgery affect long-term cancer control: a systematic review of the literature. Can J Urol 2006; 13 (Suppl. 3): 37-47
19. Wu X, Gu J, Grossman H, et al,. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006; 78: 464-79 (Pubitemid 43291228)
20. Marsit C, Karagas M, Andrew A, et al,. Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 2005; 65: 7081-5 (Pubitemid 41161235)
21. Marsit C, Karagas M, Danaee H, et al,. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis 2006; 27: 112-6 (Pubitemid 43025250)
22. Marsit C, Houseman E, Schned A, Karagas M, Kelsey K,. Promoter hypermethylation is associated with current smoking, age, sex and survival in bladder cancer. Carcinogenesis 2007; 28: 1745-51 (Pubitemid 47289037)